Skip to main content
SpringerLink
Log in

Kardiomyopathien

  • Chapter
Klinische Kardiologie

  • 1377 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abelmann WH, Lorell BH (1989) The challenge of cardiomyopathy. J Am Coll Cardiol 13: 1219–1239

    PubMed  CAS  Google Scholar 

  • Akasaka T, Yoshikawa J, Yoshida K (1994) Phasic coronary flow characteristics in patients with hypertrophic cardiomyopathy: A study by coronary doppler catheter. J Am Soc Echocardiogr 7: 9–19

    PubMed  CAS  Google Scholar 

  • Anan R, Greve G, Thierfelder L et al. (1994) Prognostic implications of novel β-myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 93: 280–285

    Article  PubMed  CAS  Google Scholar 

  • Anan R, Shono H, Kisanuki A et al. (1998) Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favourable prognosis. Circulation 98: 391–397

    PubMed  CAS  ISI  Google Scholar 

  • Arnold M, McGuire L, Lee JC (1988) Loefflers fibroplastic endocarditis. Pathology 20: 79–82

    Article  PubMed  CAS  ISI  Google Scholar 

  • Baig MK, Goldman JH, Caforio AL et al. (1998) Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 31: 195–201

    Article  PubMed  CAS  Google Scholar 

  • Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ (1994) Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol 34: 902–911

    PubMed  CAS  Google Scholar 

  • Benchimol A, Bantell H, Dressen KB (1978) Accelaterated ventricular rhythm and cocaine abuse. Ann Intern Med 88: 519–520

    PubMed  CAS  Google Scholar 

  • Berger PB, Duffy J, Reeder GS et al. (1994) Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Mayo Clin Proc 69: 162–165

    PubMed  CAS  Google Scholar 

  • Bertolet BD, Freud G, Martin CA (1990) Unrecognized left ventricular dysfunction in an apparent healthy cocaine abuse population. Clin Cardiol 13: 323–328

    PubMed  CAS  Google Scholar 

  • Bione S, D’Adamo P, Maestrini E et al. (1996) A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12: 385–389.

    Article  PubMed  CAS  Google Scholar 

  • Blair E, Redwood C, Ashrafian H et al. (2001) Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis Hum Mol Gen 10: 1215–1220

    Article  PubMed  CAS  Google Scholar 

  • Bonne G, Carrier L, Richard P et al. (1998) Familial hypertrophic cardiomyopathy. From mutations to functional defects. Circ Res 83: 580–593

    PubMed  CAS  Google Scholar 

  • Bowles NE, Ni J, Marcus F, Towbin JA (2002) The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39: 892–895

    Article  PubMed  Google Scholar 

  • Bowmann SJ, Tanna S, Fernando S et al. (1989) Anabolic steroids and infarction. BMJ 299: 632–634

    Google Scholar 

  • Brickner ME, Willard JE, Eichhorn EJ (1991) Left ventricular rhythm and cocaine abuse. Circulation 84: 1130–1135

    PubMed  CAS  ISI  Google Scholar 

  • Brugada R, Kelsey W, Lechin M et al. (1997) Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Investig Med 45: 542–551

    PubMed  CAS  Google Scholar 

  • Brush JE, Eisenhofer G, Garty M (1989) Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation 79: 836–844

    PubMed  ISI  Google Scholar 

  • Buccino RA, Spann JF, Poole PE, Braunwald E (1967) Influence of the thyroid state on the intrinsic contractile properties and the energy stores of the myocardium. J Clin Invest 46:1669

    Google Scholar 

  • Buckley WE, Yesalis CE, Friedl KE et al. (1988) Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260: 3441–3445

    Article  PubMed  CAS  ISI  Google Scholar 

  • Cannan CR, Reeder GS, Bailey KR (1995) Natural history of hypertrophic cardiomyopathy: A population based study, 1976 through 1990. Circulation 92: 2488–2495

    PubMed  CAS  ISI  Google Scholar 

  • Carlquist JF, Menlove RL, Murray MB et al. (1991) HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 83: 515–522

    PubMed  CAS  ISI  Google Scholar 

  • Cecchetti G, Binda A, Piperno A et al. (1991) Cardiac alterations in 36 consecutive patients with idiopathic hemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 12: 224–230

    PubMed  CAS  Google Scholar 

  • Cerqueira MD, Harp GD, Ritchie JL (1991) Rarity of preclinical alcoholic cardiomyopathy in chronic alcoholics <40 years of age. Am J Cardiol 67: 183–187

    Article  PubMed  CAS  Google Scholar 

  • Cetta F, OLeary PW, Seward JB, Driscoll DJ (1995) Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 70: 634–640

    PubMed  CAS  Google Scholar 

  • Cheng TO (1997) Another cause for deep T-wave inversion. ACC Curr J Rev 6: 116

    Article  Google Scholar 

  • Child JS, Perloff JK (1988) The restrictive cardiomyopathies. Cardiol Clin 6: 289–316

    PubMed  CAS  Google Scholar 

  • Codd MB, Sugrue DD, Gersh BJ, Melton LJ (1989) Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: A population based study in Olmsted County, Minnesota. Circulation 80: 564–572

    PubMed  CAS  ISI  Google Scholar 

  • Courville C, Mason VR (1938) The heart in acromegaly. Arch Intern Med 61: 704–713

    Google Scholar 

  • Dabrowska B, Dabrowski A, Pruszczy KP (1995) Heart rate variability in pheochromocytoma. Am J Cardiol 76: 1202–1204

    Article  PubMed  CAS  Google Scholar 

  • Danieli GA, Rampazzo A (2002) Genetics of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol 17: 218–221

    Article  PubMed  Google Scholar 

  • Dansky HM, Buttrick PM (1994) Unravelling the genetic basis of dilated cardiomyopathy. Heart Failure 10: 5–10

    Google Scholar 

  • Das G (1993) Cardiovascular effects of cocaine abuse. Int J Clin Pharmacol Ther Tox 31: 521–528

    CAS  Google Scholar 

  • Davies MJ, McKenna WJ (1995) Hypertrophic cardiomyopathy; Pathology and pathogenesis. Histopathology 26: 493–500

    Article  PubMed  CAS  ISI  Google Scholar 

  • Doroshow JH, Locker GY, Myers CE (1980) Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J Clin Invest 65: 128–136

    Article  PubMed  CAS  Google Scholar 

  • Durand JB, Bachinski LL, Bieling LC et al. (1995) Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 92: 3387–3389

    PubMed  CAS  ISI  Google Scholar 

  • Emanuel R, Withers R, OBrien K (1971) Dominant and recessive modes of inheritance in idiopathic cardiomyopathy. Lancet II: 1065–1067

    Article  Google Scholar 

  • Engel TR, Luck JC (1983) Effect of whiskey on atrial vulnerability and holiday heart. J Am Coll Cardiol 1: 816–818

    PubMed  CAS  Google Scholar 

  • Engelmann GL, Boehm KD, Haskell JF et al. (1989) Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in normotensive and hypertensive rats. Mol Cell Endocrinol 63: 1–14

    Article  PubMed  CAS  Google Scholar 

  • Ettinger PO, Wu CF, De La Cruz C (1978) Arrhythmics and the holiday heart: alcohol-associated cardiac rhythm disorders. Am Heart J 95: 555–562

    Article  PubMed  CAS  Google Scholar 

  • Factor SM, Butany J, Sole MJ (1991) Pathological fibrosis and matric connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 17: 1343–1351

    PubMed  CAS  Google Scholar 

  • Fagius J, Westermark K, Karlsson A (1990) Baroreflex-governed sympathetic outflow to muscle vasculature is increased in hypothyroidism. Clin Endocrinol 33: 177–185

    Article  CAS  Google Scholar 

  • Fananapazir L, Chang AC, Epstein SE, MCAreavey D (1992) Prognostic determinants in hypertrophic cardiomyopathy:Prognostic evaluation of a therapeutic strategy based on clinical, holter, hemodynamic and electrophysiological findings. Circulation 86: 730–740

    PubMed  CAS  ISI  Google Scholar 

  • Fananapazir L, Epstein ND, Curiel RV (1994) Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90: 2731–2742

    PubMed  CAS  ISI  Google Scholar 

  • Fatkin D, MacRae C, Sasaki T et al. (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341: 1715–1724

    Article  PubMed  CAS  Google Scholar 

  • Fausi AS, Harley JB, Roberts WC et al. (1982) The hypereosinophilic syndrome: clinical pathophysiologic, and therapeutic considerations. Ann Intern Med 97: 78–92

    Google Scholar 

  • Feldman T, Borow KM, Sarne DM et al. (1986) Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7: 972–979

    Google Scholar 

  • Felice PV, Sawicki J, Anto J (1993) Endomyocardial disease and eosinophilia. Angiology 44: 869–874

    Article  PubMed  CAS  ISI  Google Scholar 

  • Ferenchick GS, Kirlin P, Potts R (1991) Steroids and cardiomyopathy. How strong a connection? Phys Sportsmed 19: 107–140

    Google Scholar 

  • Fitzpatrick AP, Shapiro LM, Richards AF, Poole-Wilson PA (1990) Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 63: 114–118

    Article  PubMed  CAS  Google Scholar 

  • Fontaine G, Fontaliran F, Lascault G et al. (1994) Arrhythmogenic right ventricular dysplasia. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside. Saunders, Philadelphia, p 754

    Google Scholar 

  • Franz WM, Muller OJ, Katus HA (2001) Cardiomyopathies: from genetics to the prospect of treatment. Lancet 358: 1627–1637.

    Article  PubMed  CAS  ISI  Google Scholar 

  • Geisterfer-Lowrance AA, Kass S, Tanigawa G et al. (1990) A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62: 999–1006

    Article  PubMed  CAS  Google Scholar 

  • Gerlis LM, Schmit-Ott SC, Ho SY, Anderson RH (1993) Dysplastic conditions of the right ventricular myocardium: Uhls anomaly vs. arrhythmogenic right ventricular dysplasia. Br Heart J 69: 142–150

    Article  PubMed  CAS  Google Scholar 

  • Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine (Baltimore) 70: 246–252

    CAS  Google Scholar 

  • Glazer G (1991) Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch Intern Med 151: 1925–1933

    Article  PubMed  CAS  Google Scholar 

  • Gleichmann U, Seggewiss H, Faber L (1996) Catheter treatment of hypertrophic cardiomyopathy. Dtsch Med Wochenschr 121: 679–685

    PubMed  CAS  Google Scholar 

  • Goldfarb LG, Park KY, Cervenakova L et al. (1998) Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19: 402–403

    Article  PubMed  CAS  Google Scholar 

  • Gottdiener JS, Mathisen DJ, Barer JS (1981) Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med 94: 430–436

    PubMed  CAS  Google Scholar 

  • Griesenbach U, Ferrari S, Geddes DM, Alton EWFW (2002) Gene therapy progress and prospects: cystic fibrosis. Gene Therapy 9: 1344–1350

    Article  PubMed  CAS  ISI  Google Scholar 

  • Gross DM, Williams JC, Caapriolo C et al. (1988) Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol 61: 170–176

    Article  PubMed  CAS  Google Scholar 

  • Grunig E, Tasman JA, Kucherer H et al. (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol Oct 32: 1135–1136

    Article  Google Scholar 

  • Guse AH, Kiess W, Funk B et al. (1992) Identification and characterization of insulin-like growth factor receptors on adult rat myocytes: linkage to inositol-1,4, 5-trisohosphate formation. Endocrinology 130: 145–151

    Article  PubMed  CAS  ISI  Google Scholar 

  • Hamid MS, Norman M, Quraishi A et al. (2002) Prospective evaluation of relatives for familial arrhythmogen right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 40: 1445–1450

    Article  PubMed  Google Scholar 

  • Hausdorf G, Rieger U, Koepp P (1988) Cardiomyopathy in childhood diabetes mellitus: incidence, time of onset, and relation to metabolic control. Int J Cardiol 19: 225–333

    Article  PubMed  CAS  Google Scholar 

  • Hellerstein HK, Santiago-Stevenson D (1959) Atrophy of the heart: a correlative study of eighy five proved cases. Circulation 1: 93–126

    Google Scholar 

  • Hutchison CJ, Alvarez-Reyes M, Vaughan OA (2000) Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci 114: 9–19

    Google Scholar 

  • James TN (1994) Normal and abnormal consequences of apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV mode, the sinus node and the internodal pathways. Circulation 90: 556–573

    PubMed  CAS  ISI  Google Scholar 

  • Jarcho JA, McKenna W, Pare JAP (1989) Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 321: 1372–1378

    Article  PubMed  CAS  Google Scholar 

  • Johnson CC, Myers L, Webber LS (1995) Alcohol consumption among adolescent and young adults: The Bogalusa Heart Study, 1981-1991. Am J Public Health 85: 979–982

    Article  PubMed  CAS  Google Scholar 

  • Jones LF, Tackett RL (1990) Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery an the femoral artery to vasoactive substances. J Pharmacol Exp Ther 255: 1366–1370

    PubMed  CAS  Google Scholar 

  • Jonkman FAM, De Jong G, Fioretti PM (1997) Growth hormone in the treatment of heart failure: a new tool for the future? Eur Heart J 18: 181–184

    PubMed  CAS  Google Scholar 

  • Kahaly G, Stover C, Beyer J, Mohr-Kahaly S (1992) Relation of endocrine and cardiac fi ndings in acromegalics. J Endocrinol Invest 15: 13–18

    PubMed  CAS  Google Scholar 

  • Kamisago M, Sharma SD, DePalma SR et al. (2000) Mutations in sarcomeric protein genes as a cause of dilated cardiomyopathy. N Eng J Med 343: 1688–1696

    Article  CAS  Google Scholar 

  • Karch SB, Billingham ME (1995) Coronary artery and peripheral vascular disease in cocaine users. Coron Artery Dis 6: 220–225

    PubMed  CAS  Google Scholar 

  • Karibe A, Tobacman LS, Strand J et al. (2001) Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 103(1): 65–71

    PubMed  CAS  ISI  Google Scholar 

  • Katritsis D, Wilmshurst PT, Wendon JA et al. (1991) Primary restrictive cardiomyopathy: clinical and pathologie characteristics. J Am Coll Cardiol 18: 1230–1235

    PubMed  CAS  Google Scholar 

  • Kawai C, Yui Y, Hoshino T (1983) Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: A biopsy study. J Am Coll Cardiol 2: 834–840

    Article  PubMed  CAS  Google Scholar 

  • Kelly DP, Strauss AW (1994) Inherited cardiomyopathies. N Engl J Med 330: 930–932

    Article  Google Scholar 

  • Kennedy MC, Lawrence C (1993) Anabolic steroid abuse and cardiac death. Med J Aust 158: 346–348

    PubMed  CAS  Google Scholar 

  • Keren A, Popp RL (1992) Assignment of patients into the classification of cardiomyopathies. Circulation 86: 1622–1633

    PubMed  CAS  ISI  Google Scholar 

  • Kimura A, Harada H, Park JE et al. (1997) Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379–382

    Article  PubMed  CAS  Google Scholar 

  • Kleber HD (1988) Cocaine abuse — historical, epidemiological and psychiological perspectives. J Clin Psychiatry 49: 3–6

    PubMed  Google Scholar 

  • Klein AL, Hatle LK, Taliercio CP et al. (1991) Prognostic significance of doppler measures of diastolic function in cardiac amyloidosis. A doppler echocardiography study. Circulation 83: 808–816

    PubMed  CAS  ISI  Google Scholar 

  • Kloner RA, Hale S, Alker K, Rezkalla S (1992) The effects of acute und chronic cocaine use on the heart. Circulation 85: 407–419

    PubMed  CAS  ISI  Google Scholar 

  • Koskinen P, Kupari M (1992) Alcohol and cardiac arrhythmicas. BMJ 304: 1394–1395

    Article  PubMed  CAS  Google Scholar 

  • Koskinen P, Kupari M, Leinonen H (1990) Role of alcohol in recurrences of atrial fibrillation in persons less than 65 years of age. Am J Cardiol 66: 954–958

    Article  PubMed  CAS  Google Scholar 

  • Kramer K, Kuller L, Fisker R (1968) The increasing mortality attributed to cirrhosis and fatty liver, in Baltimore (1957-1966). Ann Int Med 69: 273–282

    PubMed  CAS  Google Scholar 

  • Kupari M, Koskinen P, Suokas A, Ventila M (1990) Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 66: 1473–1477

    Article  PubMed  CAS  Google Scholar 

  • Kushawa SS, Fallon JT, Fuster V (1997) Restrictive cardiomyopathy. N Engl J Med 336: 267–276

    Article  Google Scholar 

  • Kyle RA, Gertz MA, Greipp PR et al. (1993) Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis. Am J Hematol 44: 125–128

    Article  PubMed  Google Scholar 

  • Kyle RA, Gertz MA, Greipp PR et al. (1997) A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine. N Engl J Med 336: 1202–1207

    Article  PubMed  CAS  Google Scholar 

  • La Rosée K (1994) Funktionelle und biochemische Untersuchungen zur Wirkung von Cocain auf das menschliche Myokard. Med. Dissertation, Universität München

    Google Scholar 

  • La Rosée K, Schulz A, Böhm M, Erdmann E (1997) Kardiale Dekompensation eines Bodybuilders. Dtsch Med Wochenschr 122: 1586–1590

    Google Scholar 

  • Leung DY, Klein AL (1997) Restrictive cardiomyopathy. Diagnosis and progrostic implications. In: Otto CM (ed) Practice of clinical echocardiography. Saunders, Philadelphia

    Google Scholar 

  • Lever HM, Karam RF, Currie PJ, Healy BP (1989) Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 79: 580–588

    PubMed  CAS  ISI  Google Scholar 

  • Lewis AB (1992) Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 123: 1589–1593

    Article  PubMed  CAS  Google Scholar 

  • Lewis JF, Maron BJ (1989) Elderly patients with hypertrophic cardiomyopathy: A subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 13: 36–42

    PubMed  CAS  Google Scholar 

  • Li D, Tapscoft T, Gonzalez O et al. (1999) Desmin mutation responsible for ideopathic dilated cardiomyopathy. Circulation 100: 461–464

    PubMed  CAS  ISI  Google Scholar 

  • Lombes M, Alfaidy N, Eugene E (1995) Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 92: 175–182

    PubMed  CAS  ISI  Google Scholar 

  • Löwenstein SR, Gabow PA, Cramer J (1983) The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 143: 1882–1885

    Article  PubMed  Google Scholar 

  • Luke JL, Farb A, Virmani R, Sample RHB (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroides. Pathological and toxicological findings. J Forens Sci 35: 1441–1447

    CAS  Google Scholar 

  • MacRae C, Ghaisas N, Kass S et al. (1995) Familial hypertrophic cardiomyopathy with Wof-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 96: 1216–1220

    Article  PubMed  CAS  Google Scholar 

  • Mallat Z, Tedgui A, Fontaliran F et al. (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335: 1190–1196

    Article  PubMed  CAS  Google Scholar 

  • Manolio TA, Levy D, Garrison RJ (1991) Relation of alcohol intake to left ventricular mass: The Framingham study. J Am Coll Cardiol 17: 717–721

    PubMed  CAS  Google Scholar 

  • Marcus FI (1997) Is arrhythmogenic right ventricular dysplasia, Uhls anomaly, and right ventricular outflow tract tachycardia a spectrum of the same disease? Cardiol Rev 5: 25–29

    Article  Google Scholar 

  • Marcus FI, Fontaine GH, Guiraudon G (1982) Right ventricular dysplasia: a report of 24 adult cases. Circulation 65: 384–398

    PubMed  CAS  ISI  Google Scholar 

  • Marian AJ (2002) Modifier genes for hyperrophic cardiomyopathy. Curr Opin Cardiol 17: 242–252

    Article  PubMed  CAS  Google Scholar 

  • Marian AJ, Yu QT, Workman R et al. (1993) Angiotensin-converting enzme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085–1086

    Article  PubMed  CAS  ISI  Google Scholar 

  • Marks AR, Priori S, Memmi M et al. (2002) Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol 190: 1–6

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ (1997) Hypertrophic cardiomyopathy. Lancet 350: 127–133

    Article  PubMed  CAS  ISI  Google Scholar 

  • Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganisation in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59: 689–706

    PubMed  CAS  ISI  Google Scholar 

  • Maron BJ, Savage DD, Wolfson JK, Epstein SE (1981) Prognosis significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 48: 252–257

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (»small vessel«) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8: 545

    PubMed  CAS  Google Scholar 

  • Maron BJ, Cecchi F, McKenna WJ (1994a) Risk factors and stratification vor sudden death in patients with hypertrophic cardiomyopathy. Br Heart J 72: 13–18

    Article  Google Scholar 

  • Maron BJ, Peterson EE, Maron MS, Peterson JE (1994b) Prevalence of hypertrophic cardiomyopathy in an outpatient referred for echocardiographic study. Am J Cardiol 73: 577–580

    Article  PubMed  CAS  Google Scholar 

  • Maron BJ, Nishimura RA, McKenna WJ et al. (1999) Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 99: 2927–2933

    PubMed  CAS  ISI  Google Scholar 

  • Martin WH III, Spina RJ, Korte E (1993) Effect of hyperthyroidism of short duration on cardiac sensitivity to beta-adrenergic stimulation. J Am Coll Cardiol 19: 1185–1191

    Google Scholar 

  • Maugans TA, Coates ML (1995) Diagnosis and treatment of acromegaly. Am Fam Physician 52: 207–214

    PubMed  CAS  Google Scholar 

  • McManus BM, Bren GB, Robertson EA (1981) Hemodynamic cardiac constriction without anatomic myocardial restriction or pericardial constriction. Am Heart J 102: 134–136

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, Chetty S, Oakley CM, Goodwin JF (1980) Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol 45: 1–5

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, Deanfield J, Faruqui A (1981) Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and haemodynamic features. Am J Cardiol 47: 532–538

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, England D, Doi Y (1981) Arrhythmia in hypertrophic cardiomyopathy: 1. Influenza on prognosis. Br Heart J 46: 168–172

    Article  PubMed  CAS  Google Scholar 

  • McKenna WJ, Thiene G, Nava A et al. (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 71: 215–218

    Article  PubMed  CAS  Google Scholar 

  • McManus BM, Fleury TA, Roberts WC (1981) Fatal catecholamine crisis in pheochromocytoma. Am Heart J 102: 930

    Article  PubMed  CAS  Google Scholar 

  • McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ (1988) Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 62: 164

    Article  PubMed  CAS  Google Scholar 

  • Merola B, Cittadini A, Colao A et al. (1993) Cardiac structural and functional abnormalities in adult patients with growth hormone deficiencies. J Clin Endocrinol Metab 77: 1658–1661

    Article  PubMed  CAS  Google Scholar 

  • Mestroni L, Maisch B, McKenna WJ et al. on behalf of the Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy (1999a) Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 20: 93–102

    Article  PubMed  CAS  Google Scholar 

  • Mestroni L, Rocco C, Gregori D et al. (1999b) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 34: 181–190

    Article  PubMed  CAS  Google Scholar 

  • Michels VV, Moll PP, Miller FA et al. (1992) The frequency of familial dilated cardiomyopathy in a series of patiens with idiopathic dilated cardiomyopathy. N Engl J Med 326: 77–82

    Article  PubMed  CAS  Google Scholar 

  • Milasin J, Muntoni F, Severini GM et al. (1996) A point mutation in the 5’splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 5: 73–79

    Article  PubMed  CAS  Google Scholar 

  • Mochizuki RM, Richter KJ (1988) Cardiomyopathy and cerebrovascular accident associated with anabolic-androgenic steroid use. Phys Sportsmed 16: 109–114

    Google Scholar 

  • Mogensen J, Klausen IC, Pedersen AK et al. (1999) Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest 103: R39–R43

    Article  PubMed  CAS  Google Scholar 

  • Morano I, Ritter O, Bonz A et al. (1995) Myosin light chain-actin interaction regulates cardiac contractility. Circ Res 76: 720–725

    PubMed  CAS  Google Scholar 

  • Moutoussamy S, Kelly PA, Finidori J (1998) Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem 255: 1–11

    Article  PubMed  CAS  Google Scholar 

  • Muntoni F, Cau M, Ganau A et al. (1993) Deletion of the dystrophin muscle promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329: 921–925

    Article  PubMed  CAS  Google Scholar 

  • Nakajima-Taniguchi C, Matsui H, Eguchi N et al. (1995) A novel deletion mutation in the β-myosin heavy chain gene in hypertrophic cardiomyopathy. J Mol Cell Cardiol 27: 2607–2612

    Article  PubMed  CAS  Google Scholar 

  • Narducci WA, Wagner IC, Hendrickson TP, Jeffrey TP (1990) Anabolic steroids. A review of the clinical toxicology and diagnostic screening. Clin Toxicol 28: 287–310

    Article  CAS  Google Scholar 

  • Nigro V, Okazaki Y, Belsito et al. (1997) Identification of the Syrian Hamster cardiomyopathy gene. Hum Mol Genet 6: 601–607

    Article  PubMed  CAS  Google Scholar 

  • Niimura H, Bachinski LL, Sangwatanaroj S et al. (1998) Mutations in the gene for cardiac myosin-bindin protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338: 1248–1257

    Article  PubMed  CAS  Google Scholar 

  • Olsen EGJ, Spry CFJ (1985) Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 27: 241–254

    Article  PubMed  CAS  Google Scholar 

  • Olson TM, Michels VV, Thibodeau SN et al. (1998) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750–752

    Article  PubMed  CAS  ISI  Google Scholar 

  • Olson TM, Doan TP, Kishimoto NY et al. (2000) Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1687–1694

    Article  PubMed  CAS  Google Scholar 

  • Ortiz-Lopez R, Li H, Su J et al. (1997) Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation 95: 2434–2440

    PubMed  CAS  Google Scholar 

  • Osler WM (1905) The principles and practice of medicine, 6th edn. Appleton & Lange, Norwalk/CN, pp 820 ff

    Google Scholar 

  • Paré JAP, Fraser RG, Pirozynski WJ et al. (1961) Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy. Am J Med 31: 37–62

    Article  PubMed  Google Scholar 

  • Parillo JE (1990) Heart disease and the eosinophil. N Engl J Med 323: 1560–1561

    Article  Google Scholar 

  • Patel R, Lim DS, Reddy D et al. (2000) Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathie. J Mol Cell Cardiol 32: 2369–2377

    Article  PubMed  CAS  Google Scholar 

  • Piano MR, Schwertz DW (1994) Alcoholic heart disease: a review. Heart Lung 23: 3–17

    PubMed  CAS  ISI  Google Scholar 

  • Poetter K, Jiang H, Hassanzadeh S et al. (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13: 63–69

    Article  PubMed  CAS  Google Scholar 

  • Polikar R, Burger AG, Scherrer U, Nicod P (1993) The thyroid and the heart. Circulation 87: 1435–1441

    PubMed  CAS  ISI  Google Scholar 

  • Rampazzo A, Nava A, Danieli GA et al. (1994) The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 3: 959–964

    Article  PubMed  CAS  Google Scholar 

  • Rampazzo A, Nava A, Erne P et al. (1995) A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 4:2. 151–157

    Google Scholar 

  • Regan TJ (1990) Alcohol and the cardiovascular system. JAMA 264: 377–381

    Article  PubMed  CAS  ISI  Google Scholar 

  • Richardson P, McKenna W, Bristow W et al. (1996) Report of the 1995 World Health Organization/International Society and Feration of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93: 841–842

    PubMed  CAS  ISI  Google Scholar 

  • Robinson K, Frenneaux MP, Stockins B (1990) Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study. J Am Coll Cardiol 15: 1279–1285

    PubMed  CAS  Google Scholar 

  • Rossi GP, Sacchetto A, Pavan E (1997) Remodeling of the left ventricle in primary aldosteronism due to Conns adenoma. Circulation 95: 1471–1478

    PubMed  CAS  ISI  Google Scholar 

  • Ruder MA, Winston SA, Davis JC et al. (1985) Arrhythmogenic right ventricular dysplasia in a family. Am J Cardiol 59: 799–803

    Article  Google Scholar 

  • Ruvers H, Garrahy P, Robinson W, Murphy A (1987) Reversible cardiac dysfunction in hemochromatosis. Am Heart J 113: 216–217

    Article  Google Scholar 

  • Sacca L, Cittadini A, Fazio S (1994) Growth hormone and the heart. Endocrin Rev 15: 555–573

    Article  CAS  Google Scholar 

  • Saraiva MJ (1995) Transthyretin mutations in health and disease. Hum Mutat 5: 191–196

    Article  PubMed  CAS  Google Scholar 

  • Scheidt W von, Eng CM, Fitzmaurice TF et al. (1991) An atypical variant of Fabrys disease with manifestation confined to the myocardium N Engl J Med 324: 395–399

    Article  Google Scholar 

  • Schnabel P, Mies F, Böhm M (1999) Hormontherapie bei Herzinsuffizienz. Wachstumshormon und Insulin-like growth factor-I. Z Kardiol 88: 1–9

    Article  PubMed  CAS  Google Scholar 

  • Schulman LN, Braunwald E (1997) Hematological-oncological disorders and heart disease. In: Braunwald E (ed) Heart disease. A textbook of cardiovascular medicine. Saunders, Philadelphia, pp 1786–1808

    Google Scholar 

  • Scott I, Parkes R, Cameron DP (1988) Pheochromocytoma and cardiomyopathy. Med J Aust 148: 94–99

    PubMed  CAS  Google Scholar 

  • Shabetai R (1992) Controversial issues in restrictive cardiomyopathy. Postgrad Med J 68: 47–51

    Google Scholar 

  • Shamim W, Yousufuddin M, Wang D et al. (2002) Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomypathy. N Engl J Med 347: 1326–1333

    Article  PubMed  Google Scholar 

  • Sharma OP (1994) Myocardial sarcoidosis. A wolf in sheeps clothing. Chest 106: 988–990

    Article  PubMed  CAS  ISI  Google Scholar 

  • Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346: 211–214

    Article  PubMed  CAS  ISI  Google Scholar 

  • Siveski-Iliskovic N, Kaul N, Singal PK (1994) Probucol promotes endogenous antioxidants and provides against adriamycin-induced cardiomyopathy in rats. Circulation 89: 2829–2835

    PubMed  CAS  Google Scholar 

  • Skinner M, Anderson JJ, Simms R et al. (1996) Treatment of 100 patients with primary amyloidisis; a randomized trial of melphalan, prednisone, and colchicine vs. colchicine alone. Am J Med 100: 290–298

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Chiarella F, Carratino L (1989) Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatients population. N Engl J Med 320: 749–755

    Article  PubMed  CAS  Google Scholar 

  • Spirito P, Maron BJ (1984) Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: Assessment by two-dimensional echocardiography. Am J Cardiol 54: 1039–1046

    Article  PubMed  CAS  Google Scholar 

  • Spyrou N, Foale R (1994) Restrictive cardiomyopathies. Curr Opin Cardiol 9: 344–348

    Article  PubMed  CAS  Google Scholar 

  • Stafford WJ, Trohman RG, Bilsker M (1986) Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 7: 701–704

    PubMed  CAS  Google Scholar 

  • Thiene G, Nava Am Abgekubu A et al. (1990) Anatomoclinical aspects of arrhythmogenic right ventricular cardiomyopathy. In: Baroldi G, Camerini F, Goodwin FJ (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York, pp 397–408

    Google Scholar 

  • Thiene G, Basso C, Danieli GA et al. (1997) Arrhythmogenic right ventricular cardiomyopathy. A still uncrecognized clinic entity. Trends Cardiovasc Med 7: 8492

    Article  Google Scholar 

  • Thierfelder L (1998) Genetics of dilated cardiomyopathy. Med Klin 93: 210–214

    Article  CAS  Google Scholar 

  • Thierfelder L, MacRae C, Watkins H et al. (1993) A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 90: 6270–6274

    Article  PubMed  CAS  Google Scholar 

  • Thierfelder L, Watkins H, MacRae C et al. (1994) α-Tropomyosin and cardiac troponin-T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 77: 701–712

    Article  PubMed  ISI  Google Scholar 

  • Towbin JA (1998) The role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 10: 131–139

    Article  PubMed  CAS  Google Scholar 

  • Uhl HSM (1972) A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hos 91: 197–209

    Google Scholar 

  • Urbano-Marquez A, Estruch R, Fernandez Sola J (1995) The greater risk of alcoholic cardiomyopathy and myopathy in women compared to men. J Am Coll Cardiol 274: 149–154

    CAS  Google Scholar 

  • Urhausen A, Hölpes R, Kindermann W (1989) One-and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol 58: 633–640

    Article  CAS  Google Scholar 

  • Van Dyke C, Byck R (1982) Cocaine. Sci Am 246: 128–141

    PubMed  Google Scholar 

  • Vulpian A (1868) Contribution à létude des rétrécissements de lorifice ventriculo-aortique. Arch Physiol 3: 456–457

    Google Scholar 

  • Watkins H, McKenna WJ, Thierfelder et al. (1995) Mutations in the genes for cardiac troponin T and a-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058–1064

    Article  PubMed  CAS  Google Scholar 

  • Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83: 2759–2779

    PubMed  CAS  ISI  Google Scholar 

  • Werbel SS, Ober KP (1995) Pheochromocytoma: Update on diagnosis, localization, and management. Med Clin North Am 79: 131–153

    PubMed  CAS  Google Scholar 

  • White PC (1994) Disorders of aldosterone biosynthesis and action. N Engl J Med 331: 250–258

    Article  PubMed  CAS  Google Scholar 

  • WHO (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation 93: 841–842

    Google Scholar 

  • WHO/ISFC Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies (1996). Circulation 93: 841–842

    Google Scholar 

  • Yamabe H, Okumura K, Tsuchiya T (1994) Demonstration of entrainment and presence of slow conduction during ventricular tachycardia in arrhythmogenic right ventricular dysplasia. PACE 17: 172–178

    PubMed  CAS  ISI  Google Scholar 

  • Yamaguchi H, Ishimura T, Nishiyam S (1979) Hypertrophic nonobstructive cardiomyopathy with giant negative T-waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44: 401–423

    Article  PubMed  CAS  Google Scholar 

  • Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H et al. (1996) Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene. Heart 76: 63–65

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Kirrberger Str., 66421, Homburg/Saar, Germany

    M. Böhm & H. Kilter

Authors
  1. M. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Kilter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik III für Innere Medizin, Klinikum der Universität zu Köln, Kerpener Str. 62, 50937, Köln, Germany

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Böhm, M., Kilter, H. (2006). Kardiomyopathien. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-29425-2_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23742-6

  • Online ISBN: 978-3-540-29425-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation